Krystal Biotech, Inc.

Today we observe World Lung Cancer Day – which is dedicated to raising awareness about lung cancer, its impact, and the importance of early detection and treatment. We honor all of those who have been impacted by lung cancer and continue our research efforts in this area. #WorldLungCancerDay

🏆 Nous sommes fiers d'annoncer que Krystal Biotech a été sélectionné au Prix Galien France 2025 dans la catégorie « thérapie innovante » ! Krystal Biotech a développé une thérapie génique indiquée pour le traitement des plaies chez les patients atteints d'une maladie cutanée rare dès le plus jeune âge. 🔬 Cette nomination récompense le travail remarquable de nos équipes et notre engagement auprès des patients atteints de maladies rares. #InnovationSanté #ThérapieGénétique #MaladiesRares #KrystalBiotech #PrixGalien 🏆 We are proud to announce that Krystal Biotech has been nominated for the 2025 Prix Galien France in the innovative therapy category! Krystal Biotech has developed a gene therapy indicated for the treatment of wounds in patients with a rare skin disease from an early age. 🔬 This nomination recognizes the tremendous work of our teams and our commitment to patients with rare diseases.   #HealthInnovation #GeneTherapy #RareDiseases #KrystalBiotech #PrixGalien

Forbes has named Krystal founder Suma Krishnan to the 2025 Class of 50 over 50, a group of female STEM standouts whose leadership is actively advancing the world’s understanding of medicine, meteorology and large language models. https://lnkd.in/gkEepw8

Investor News: Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa   Read more: https://krys.bio/nhw

Investor News: Jeune Announces Positive Results and Significant Aesthetic Improvements from Phase 1 Study of KB304 for Moderate to Severe Wrinkles of the Décolleté   Read more: https://krys.bio/02w

Krystal Biotech is a proud sponsor of the 50th Annual Meeting of the Society for Pediatric Dermatology. Our team is looking forward to being in Seattle the next few days with the experts in pediatric dermatology for this meeting. #pedsderm 

The Krystal team was proud to support debra of America for this year's first EB Community Regional Meetups in NYC hosted by leading medical professionals and researchers in Epidermolysis Bullosa. Great day of connecting with those living with EB & their families!

Investor News: Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis   Read Here: https://krys.bio/nkt

Happy Independence Day! Today our team in the United States celebrates freedom, unity, and the spirit of progress. Wishing you a safe and joyful Independence Day! 🎆 #FourthOfJuly #IndependenceDay

Krystal recognizes #Juneteenth, which commemorates the end of slavery in the United States. As we reflect today, we continue to recognize that diversity, equity, and inclusion are essential in our workplace and community.